| ABSTRACTThe status of global diabetes related clinical research registration and publication was analyzed by searching statistical authority clinical research register and pubmed database, and at the same time, the current situation in China was analyzed. Analysis showed that the number of clinical studies on diabetes in the world was still low while the total number of clinical studies on diabetes in China was also low. However, the data of the past ten years showed that the number of clinical studies on diabetes in China upward trend year by year. Researches mainly included the insulin, metformin, dipeptidyl peptidase 4 inhibitor (DPP4i), glucagon like peptide 1 (GLP 1) analogs, sodium glucose cotransporter 2 inhibitor (SGLT2i), in which DPP4i, GLP 1 analogs and SGLT2i had become hot in recent years. Overall, the clinical research on diabetes was weak and the registration of clinical studies of diabetes at home and abroad had been on the rise year by year, and had changed to a new type of hypoglycemic drug. |
